These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2885989)
1. [Therapy of seronegative oligoarthritis with salazopyrine]. Stroehmann I; Wüstenhagen E; Martini M Z Rheumatol; 1987; 46(2):79-82. PubMed ID: 2885989 [TBL] [Abstract][Full Text] [Related]
2. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. Clegg DO; Reda DJ; Abdellatif M Arthritis Rheum; 1999 Nov; 42(11):2325-9. PubMed ID: 10555027 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine]. Suschke HJ Monatsschr Kinderheilkd; 1992 Sep; 140(9):658-60. PubMed ID: 1359405 [TBL] [Abstract][Full Text] [Related]
4. Treatment of the seronegative spondyloarthropathies with sulfasalazine. Zwillich SH; Comer SS; Lee E; Erdman WA; Lipsky PE J Rheumatol Suppl; 1988 Sep; 16():33-9. PubMed ID: 2903925 [TBL] [Abstract][Full Text] [Related]
6. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab. Schatteman L; Gyselbrecht L; De Clercq L; Mielants H J Rheumatol; 2006 Jan; 33(1):82-5. PubMed ID: 16292792 [TBL] [Abstract][Full Text] [Related]
7. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitis. van Denderen JC; van der Horst-Bruinsma I; Bezemer PD; Dijkmans BA J Rheumatol; 2003 Jul; 30(7):1558-60. PubMed ID: 12858458 [TBL] [Abstract][Full Text] [Related]
9. Six months open label trial of leflunomide in active ankylosing spondylitis. Haibel H; Rudwaleit M; Braun J; Sieper J Ann Rheum Dis; 2005 Jan; 64(1):124-6. PubMed ID: 15608310 [TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis. Marzo-Ortega H; Green MJ; Keenan AM; Wakefield RJ; Proudman S; Emery P Arthritis Rheum; 2007 Feb; 57(1):154-60. PubMed ID: 17266089 [TBL] [Abstract][Full Text] [Related]
11. Arthritis associated with HIV infection in Zimbabwe. Stein CM; Davis P J Rheumatol; 1996 Mar; 23(3):506-11. PubMed ID: 8832993 [TBL] [Abstract][Full Text] [Related]
12. A long-term study of flurbiprofen in rheumatological disorders: III. Other articular conditions. Busson M J Int Med Res; 1986; 14(1):13-8. PubMed ID: 3514311 [TBL] [Abstract][Full Text] [Related]
13. [Retinoid in the treatment of psoriatic arthropathy: a pilot study]. Rosenthal M Schweiz Med Wochenschr; 1979 Dec; 109(48):1912-4. PubMed ID: 538432 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of ankylosing spondylitis with salazosulfapyridine. A controlled double-blind study in 60 patients]. Dougados M; Boumier P; Amor B Rev Rhum Mal Osteoartic; 1987 Mar; 54(3):255-60. PubMed ID: 2884723 [TBL] [Abstract][Full Text] [Related]
15. Clinical comparison of patients with ankylosing spondylitis, Reiter's syndrome and psoriatic arthritis. Deesomchok U; Tumrasvin T J Med Assoc Thai; 1993 Feb; 76(2):61-70. PubMed ID: 8228701 [TBL] [Abstract][Full Text] [Related]
16. [Pharmachem's salazopyrine in rheumatoid arthritis]. Konstantinova M; Konstantinova V Vutr Boles; 1990; 29(5):65-8. PubMed ID: 1981958 [TBL] [Abstract][Full Text] [Related]
18. Cyclosporine in the treatment of psoriatic arthritis. Gupta AK; Matteson EL; Ellis CN; Ho VC; Tellner DC; Voorhees JJ; McCune WJ Arch Dermatol; 1989 Apr; 125(4):507-10. PubMed ID: 2930208 [TBL] [Abstract][Full Text] [Related]
19. Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial. Wei JC; Chan TW; Lin HS; Huang F; Chou CT J Rheumatol; 2003 Dec; 30(12):2627-31. PubMed ID: 14719205 [TBL] [Abstract][Full Text] [Related]
20. Two years of experience with etanercept in recalcitrant psoriasis. Ahmad K; Rogers S Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]